December 8, 2023

6th EPHA Universal Access and Affordable Medicines Forum

The forum serves as a platform for facilitating discussions regarding pharmaceutical and medicine policies in...

January 18, 2022

Transparency of (real) pharmaceutical costs

High prices of new medicines are affecting patient access across Europe. They are justified by...

June 15, 2021

The Oslo Medicines Initiative: a new social contract with pharma

Join us for the eighth EPHA #A2MDialogues to discuss the Oslo Medicines Initiative

December 8, 2020

Getting it right: Recommendations for a European BARDA

Join us for the fifth of the #A2MDialogues to discuss the development of an European...

November 25, 2020

The Presidencies’ perspective on the pharmaceutical strategy: Europe’s to-do list on access to medicines

EPHA’s fourth #A2MDialogue follows the publication of the EU’s Pharmaceutical Strategy by the European Commission....

November 19, 2020

Pharma & COVID19: Winners, losers, prospects

From the onset of the COVID-19 pandemic, governments turned to the pharmaceutical sector for answers...

October 20, 2020

Unleashing meaningful innovation through regulatory reform

Join EPHA for our first online Access to Medicines Dialogue to discuss how regulatory and...

Get the EPHA Newsletter

Get involved !

Get involved !

Sign up here to receive our updates on European health policy and invitations to our events.

Subscribe now

You have Successfully Subscribed!